Sumitomo Heavy Industries builds cyclotron-based proton therapy systems for centres including Samsung Medical Center and Chang Gung Memorial Hospital, medical cyclotrons for PET isotopes, and the first approved accelerator for boron neutron capture therapy.
Sumitomo Heavy Industries, an engineering group founded in 1888, supplies isochronous cyclotron proton therapy systems with scanning gantries to hospitals in Japan, South Korea (Samsung Medical Center), Taiwan (Chang Gung Memorial Hospital) and elsewhere, and its HM-series cyclotrons produce fluorine-18 and other PET isotopes in hospital radiopharmacies. Its accelerator-based neutron source for boron neutron capture therapy was approved in Japan in 2020 for head and neck cancer with Stella Pharma's borofalan. OnCo links it to proton therapy machines, medical cyclotrons and BNCT.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy and the tag machines-wave.
Shares Boron neutron capture therapy, Accelerator-based BNCT systems (NeuCure, nuBeam, NeuPex), Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy and the tag machines-wave.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems, Proton therapy and the tag machines-wave.
Shares Samsung Medical Center and the tag machines-wave.
Shares Proton therapy machines: cyclotrons, synchrotrons and single-room systems and the tag machines-wave.
Shares Boron neutron capture therapy, Accelerator-based BNCT systems (NeuCure, nuBeam, NeuPex).
Shares Boron neutron capture therapy, Accelerator-based BNCT systems (NeuCure, nuBeam, NeuPex).
Shares Boron neutron capture therapy, Accelerator-based BNCT systems (NeuCure, nuBeam, NeuPex).